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CASE REPORT
Multiple Granulocytic Sarcomas in a Patient with 
Longstanding Complete Remission of Acute 
Myelogenous Leukemia
Hee-Dam Jung, M.D., Hei-Sung Kim, M.D., Young-Min Park, M.D., Hyung-Ok Kim, M.D., 
Jun-Young Lee, M.D.
Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Granulocytic sarcoma is an extramedullary tumor composed 
of granulocytic precursor cells. It usually presents as a 
nodular mass in the course of acute myelogenous leukemia. 
Rarely, the tumor develops in non-hematological conditions 
or in a patient with complete remission from the acute 
myelogenous leukemia. In such cases, aleukemic granulo-
cytic sarcoma can be a preceding sign of systemic leukemia 
or a first sign of hematologic relapse of leukemia. We present 
an unusual case of multiple granulocytic sarcomas develo-
ped in a patient with longstanding complete remission of 
acute myelogenous leukemia, who has not had bone 
marrow and peripheral blood involvement for a long time. 
(Ann Dermatol 23(S2) S270∼S273, 2011)
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INTRODUCTION
Granulocytic sarcomas usually occur during the course of 
acute myelogenous leukemia (AML) and antecede blastic 
cirisis in myeloproliferative disease or myelodysplastic 
syndromes. However, the tumor can also develop in 
patients who have either no prior history of hematological 
disease or have shown complete remission from acute 
myelogenous leukemia.
Herein, we describe a patient who has shown an unusual 
clinical course in that she was in complete remission from 
AML for a long time and that there were no signs of 
peripheral blood and bone marrow relapse for a long time 
following the development of granulocytic sarcoma.
CASE REPORT
A 72-year-old Korean woman presented with a 1-month 
history of rapidly growing multiple cutaneous nodules on 
the whole body. Physical examination revealed wide-
spread well-demarcated variable-sized greenish firm 
cutaneous nodules over the face, trunk and extremities 
(Fig. 1). 
She had a history of acute myeloblastic leukemia without 
maturation (AML M1), and achieved complete remission 
after the 3rd consolidation chemotherapy, ten years ago. 
The patient remained asymptomatic for nine years and 
then visited the hospital presenting with an asymptomatic 
solitary firm mass on the left upper eyelid in September 
2009. An excisional biopsy of the lesion was performed 
and histopathologic findings were consistent with a 
granulocytic sarcoma. Bone marrow biopsy showed 
normocellular bone marrow without leukemic cell 
involvement and peripheral blood also revealed normal 
findings. In April 2010, she complained of nasal stuffiness, 
bloody nasal discharge and hoarseness. Neck computed 
tomography and magnetic resonance imaging findings Multiple Granulocytic Sarcomas
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Fig. 1. (A, B) Widespread well-de-
marcated variable-sized greenish firm 
cutaneous nodules over the face, 
trunk and extremities.
Fig. 2. (A) Dense cellular infiltrate
among collagen bundles and in the
perifollicular areas within the en-
tire dermis (H&E, original magni-
fication ×40). (B) Higher magnifi-
cation reveals homogenous atypi-
cal cells with round to oval shaped
hyperchromatic nuclei (H&E, origi-
nal magnification ×400).
showed a mass in the nasopharynx. Histopathologic 
findings of this lesion are also consistent with granulocytic 
sarcoma. At that time, there was no systemic involvement 
of leukemia. Although she was referred to the Department 
of Hematology, she refused systemic treatment. In Sep-
tember 2010, she visited our clinic due to the multiple 
skin lesions. On laboratory examination, the white blood 
cell count was 6·2×10
9 L
-1 with 69% segmented 
neutrophils, 24% lymphocytes, 7% monocytes, 0% 
eosinophils and 0% basophils, without evidence of 
abnormal cells. The red blood cell count, platelet count 
and hemoglobin level were all within the normal range. 
Bone marrow biopsy showed a normocellular bone 
marrow without leukemic cell involvement. Histo-
pathological examination of a skin biopsy specimen from 
the trunk revealed a dense cellular infiltrate among 
collagen bundles and in the perifollicular areas within the 
entire dermis (Fig. 2A). The infiltrate consisted of homo-
genous atypical cells with round to oval hyperchromatic 
nuclei (Fig. 2B). Tumor cells are positive for Leder stain 
and immunoperoxidase (Fig. 3A), but negative for CD3, 
CD20, CD34, TdT and Pax-5 (Fig. 3B).
From pathological and immunohistological findings, we 
confirmed the diagnosis of granulocytic sarcoma for the 
skin lesions. The patient was transferred to hematology 
again for proper management, but she refused the treat-
ment for personal reasons.HD Jung, et al
S272 Ann Dermatol
Fig. 3. (A) Tumor cells are positive for Leder stain and immunoperoxidase (original magnification ×400). (B) Tumor cells are negative
for CD3, CD20, CD34, TdT and Pax-5 (original magnification ×40).
DISCUSSION
Granulocytic sarcoma is an extramedullary tumor com-
posed of granulocytic precursor cells, such as myeloblast 
or immature myeloid cells. It is also known as myeloid 
sarcoma, extramedullary tumor and chloroma. Granu-
locytic sarcoma clinically manifests as a solid nodular 
mass, which commonly affects the bone, periosteum, 
lymph node and skin. Granulocytic sarcomas usually 
occur during the course of AML and antecede blastic 
cirisis in myeloproliferative disease or myelodysplastic 
syndromes
1-5. However, the tumor can also develop in 
patients who have either no prior history of hematological 
disease or have shown complete remission from acute 
myelogenous leukemia
6-11. Aleukemic granulocytic sarco-
ma is very rare. It usually precedes systemic relapse in 
most cases.
The pathogenesis of aleukemic granulocytic sarcoma is 
yet to be elucidated. Takahashi et al.
12 suggested that 
clonal evolution might be related to conversion of the 
character of leukemic blasts. Up-regulating expression of 
some adhesion molecules in the AML-M3 patient treated 
with all-trans retinoic acid was also hypothesized
7. 
However, our patient had a history of AML-M1, and 
cytogenetic analysis of the granulocytic sarcoma revealed 
no chromosomal abnormality with 46, XX. These facts do 
not fit with the above conditions. In terms of a molecular 
basis, the homing of T cells into the skin via interaction 
with integrins and endothelial-bound chemokines is 
suggested as a mechanism of extramedullary invasion of 
leukemic cells
13.
In the diagnosis of granulocytic sarcoma, histopathologic 
examination is necessary. Immunohistochemical studies of 
the lesions and history of underlying systemic leukemia 
are helpful in differential diagnosis with lymphoma, 
mycosis fungoides and other neoplasms. In a retrospective 
review, Cronin et al.
14 documented that myeloperoxidase 
expression strongly supports the diagnosis of myeloid 
leukemia cutis.
The treatment of aleukemic granulocytic sarcoma has not 
been established. Chemotherapy or radiotherapy is 
usually recommended. Several studies have suggested that 
aggressive chemotherapy at the time of diagnosis of 
aleukaemic granulocytic sarcoma may improve the overall 
survival rate and help prevent subsequent progression to 
AML
15,16.
The prognosis of aleukemic granulocytic sarcoma is poor. 
In such cases, relapse of leukemia occurs within a mean Multiple Granulocytic Sarcomas
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of 10 months following granulocytic sarcoma
1,9. Rarely, 
overt leukemia can occur after a long period since the 
onset of granulocytic sarcoma
17.
Our patient has shown an unusual clinical course in that 
she was in complete remission from AML for a long time 
and that there were no signs of systemic involvement for a 
long time following the development of granulocytic 
sarcoma. She remained asymptomatic for a long time after 
achieving complete remission of AML M1. Nine years 
later, she presented with multiple granulocytic sarcoma. 
Although cutaneous multiple lesions show a tendency to 
progress rapidly, no systemic leukemic involvement has 
been observed for seventeen months of the follow-up 
period.
From our case, we see that multiple granulocytic sarcomas 
can develop even in patients who have shown complete 
remission of AML for an extended period of time. 
Therefore, we think that careful periodic follow-up 
including hematologic evaluation is needed for such 
patients as aleukemic granulocytic sarcoma can be a first 
sign of hematologic relapse of leukemia.
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